Biotech startup is creating genetically engineered 'superblood' to battle cancer

“The addition of this funding further strengthens our foundation and enables us to accelerate the development of our first wave of RCT products that are targeting treatment of enzyme deficiencies, cancer, and autoimmune disease,” Torben Straight Nissen, president of Rubius Therapeutics, said in a …
Read more: Biotech startup is creating genetically engineered 'superblood' to battle cancer

Please Login to Comment.